Medical device company Vascular Grafts Solutions Friday provided interim results from the the post-marketing VEST III study that evaluates the effectiveness of the VEST technology (Venous External SupporT) in treatment of saphenous vein graft
(SVG) disease after coronary artery bypass grafting.
He had a left internal mammary artery to the left anterior descending coronary artery, saphenous vein graft
(SVG) to diagonal branch, and SVG to obtuse marginal artery.
Improvement in early saphenous vein graft
patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
This is currently the largest trial with long-term outcome data comparing these two types of stents in saphenous vein graft
disease, and will reassure clinicians about the use of DES for this specific indication, noted principal investigator Raban Jeger, MD, from University Hospital, in Basel, Switzerland.
Off-pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft
patency and less effective revascularization: results from the Veterans Affairs Randomized On/Off Bypass (ROOBY) trial.
Saphenous vein graft
aneurysms are a rare complication of coronary bypass surgery and can be divided into true and pseudo-aneurysms.
Postoperative aspirin, started within 6 hours of surgery, improves saphenous vein graft
Additionally the saphenous vein graft
site in the (R) LE became infected.
Preoperative evaluation revealed a history of diabetes mellitus, heavy smoking and coronary artery bypass grafting four years ago, including an in situ LIMA graft to LAD coronary artery and a saphenous vein graft
from the aorta to the obtuse marginal artery.
Aortocoronary saphenous vein graft
disease: Pathogenesis, predisposition, and prevention.
The 7F Proxis Embolic Protection System is intended to extract debris that may become dislodged when an intervention, such as delivering a stent, is performed on patients who previously have undergone a heart bypass procedure using a saphenous vein graft
The application for 510(k) clearance contains data from Kensey Nash's PRIDE (PRotection during saphenous vein graft
Intervention to prevent Distal Embolization) trial which compared the TriActiv device against other approved embolic protection systems for the treatment of saphenous vein graft